Back to Search
Start Over
Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation.
- Source :
-
Disease models & mechanisms [Dis Model Mech] 2010 Mar-Apr; Vol. 3 (3-4), pp. 224-35. Date of Electronic Publication: 2010 Feb 08. - Publication Year :
- 2010
-
Abstract
- Long bone development depends on endochondral bone formation, a complex process requiring exquisite balance between hypertrophic cartilage (HC) formation and its ossification. Dysregulation of this process may result in skeletal dysplasias and heterotopic ossification. Endochondral ossification requires the precise orchestration of HC vascularization, extracellular matrix remodeling, and the recruitment of osteoclasts and osteoblasts. Matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEGF) and osteoclasts have all been shown to regulate endochondral ossification, but how their function interrelates is not known. We have investigated the functional relationship among these regulators of endochondral ossification, demonstrating that they have complementary but non-overlapping functions. MMP-9, VEGF and osteoclast deficiency all cause impaired growth plate ossification resulting in the accumulation of HC. VEGF mRNA and protein expression are increased at the MMP-9-/- growth plate, and VEGF activity contributes to endochondral ossification since sequestration of VEGF by soluble receptors results in further inhibition of growth plate vascularization and ossification. However, VEGF bioavailability is still limited in MMP-9 deficiency, as exogenous VEGF is able to rescue the MMP-9-/- phenotype, demonstrating that MMP-9 may partially, but not fully, regulate VEGF bioavailability. The organization of the HC extracellular matrix at the MMP-9-/- growth plate is altered, supporting a role for MMP-9 in HC remodeling. Inhibition of VEGF impairs osteoclast recruitment, whereas MMP-9 deficiency leads to an accumulation of osteoclasts at the chondro-osseous junction. Growth plate ossification in osteoclast-deficient mice is impaired in the presence of normal MMP-9 expression, indicating that other osteoclastic functions are also necessary. Our data delineate the complementary interplay between MMP-9, VEGF and osteoclast function that is necessary for normal endochondral bone formation and provide a molecular framework for investigating the molecular defects contributing to disorders of endochondral bone formation.
- Subjects :
- Acid Phosphatase metabolism
Animals
Animals, Newborn
Bone and Bones drug effects
Bone and Bones enzymology
Bone and Bones pathology
Bone and Bones ultrastructure
Cartilage pathology
Cartilage ultrastructure
Chondrocytes drug effects
Chondrocytes enzymology
Chondrocytes ultrastructure
Collagen Type II metabolism
Extracellular Matrix drug effects
Extracellular Matrix metabolism
Extracellular Matrix ultrastructure
Growth Plate drug effects
Growth Plate enzymology
Growth Plate pathology
Growth Plate ultrastructure
Humans
Hypertrophy
Isoenzymes metabolism
Matrix Metalloproteinase 9 deficiency
Matrix Metalloproteinase Inhibitors
Mice
Models, Biological
Osteoclasts drug effects
Osteoclasts ultrastructure
Phenotype
Protease Inhibitors pharmacology
Tartrate-Resistant Acid Phosphatase
Vascular Endothelial Growth Factor A antagonists & inhibitors
Vascular Endothelial Growth Factor A pharmacology
Chondrocytes pathology
Matrix Metalloproteinase 9 metabolism
Osteoclasts enzymology
Osteoclasts pathology
Osteogenesis drug effects
Vascular Endothelial Growth Factor A metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1754-8411
- Volume :
- 3
- Issue :
- 3-4
- Database :
- MEDLINE
- Journal :
- Disease models & mechanisms
- Publication Type :
- Academic Journal
- Accession number :
- 20142327
- Full Text :
- https://doi.org/10.1242/dmm.004226